{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T00:23:41Z","timestamp":1715473421816},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,11]]},"DOI":"10.7759\/cureus.60101","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T17:08:43Z","timestamp":1715447323000},"source":"Crossref","is-referenced-by-count":0,"title":["A Presentation of Meige Syndrome With Associated Upper Motor Neuron Symptoms"],"prefix":"10.7759","author":[{"given":"Jeffrey","family":"Valencia Uribe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassnain","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2009.04.006","article-title":"Meige syndrome: what's in a name?","volume":"15","author":"LeDoux MS","year":"2009","unstructured":"LeDoux MS. Meige syndrome: what's in a name?. Parkinsonism Relat Disord. 2009, 15:483-9. 10.1016\/j.parkreldis.2009.04.006","journal-title":"Parkinsonism Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8575-z","article-title":"Henri Meige (1866-1940)","volume":"264","author":"Owecki MK","year":"2017","unstructured":"Owecki MK, Bogusz H, Magowska A. Henri Meige (1866-1940). J Neurol. 2017, 264:2348-50. 10.1007\/s00415-017-8575-z","journal-title":"J Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.630221","article-title":"Blepharospasm, oromandibular dystonia, and Meige syndrome: clinical and genetic update","volume":"12","author":"Ma H","year":"2021","unstructured":"Ma H, Qu J, Ye L, Shu Y, Qu Q. Blepharospasm, oromandibular dystonia, and Meige syndrome: clinical and genetic update. Front Neurol. 2021, 12:630221. 10.3389\/fneur.2021.630221","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2015.02.015","article-title":"The spread of primary late-onset focal dystonia in a long-term follow up study","volume":"132","author":"Svetel M","year":"2015","unstructured":"Svetel M, Pekmezovic T, Tomic A, Kresojevic N, Kostic VS. The spread of primary late-onset focal dystonia in a long-term follow up study. Clin Neurol Neurosurg. 2015, 132:41-3. 10.1016\/j.clineuro.2015.02.015","journal-title":"Clin Neurol Neurosurg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321794","article-title":"Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study","volume":"91","author":"Berman BD","year":"2020","unstructured":"Berman BD, Groth CL, Sillau SH, et al.. Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study. J Neurol Neurosurg Psychiatry. 2020, 91:314-20. 10.1136\/jnnp-2019-321794","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","unstructured":"Meige syndrome. (2023). Accessed. October 10, 2023: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513358\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.11.053","article-title":"Meige's syndrome: history, epidemiology, clinical features, pathogenesis and treatment","volume":"372","author":"Pandey S","year":"2017","unstructured":"Pandey S, Sharma S. Meige's syndrome: history, epidemiology, clinical features, pathogenesis and treatment. J Neurol Sci. 2017, 372:162-70. 10.1016\/j.jns.2016.11.053","journal-title":"J Neurol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71479-9","article-title":"Grey matter changes in Meige syndrome: a voxel-based morphology analysis","volume":"10","author":"Liu J","year":"2020","unstructured":"Liu J, Li L, Chen L, et al.. Grey matter changes in Meige syndrome: a voxel-based morphology analysis. Sci Rep. 2020, 10:14533. 10.1038\/s41598-020-71479-9","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","author":"Brin MF","year":"2001","unstructured":"Brin MF, Lyons KE, Doucette J, et al.. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology. 2001, 56:1523-8. 10.1212\/wnl.56.11.1523","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000052135","article-title":"Radiculopathy and myelopathy in patients with primary cervical dystonia","volume":"45","author":"Hagenah JM","year":"2001","unstructured":"Hagenah JM, Vieregge A, Vieregge P. Radiculopathy and myelopathy in patients with primary cervical dystonia. Eur Neurol. 2001, 45:236-40. 10.1159\/000052135","journal-title":"Eur Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28042","article-title":"Abnormal neural responses during reflexive blinking in blepharospasm: an event-related functional MRI study","volume":"35","author":"Nguyen P","year":"2020","unstructured":"Nguyen P, Kelly D, Glickman A, Argaw S, Shelton E, Peterson DA, Berman BD. Abnormal neural responses during reflexive blinking in blepharospasm: an event-related functional MRI study. Mov Disord. 2020, 35:1173-80. 10.1002\/mds.28042","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000027361.73814.0e","article-title":"Blepharospasm: recent advances","volume":"59","author":"Hallett M","year":"2002","unstructured":"Hallett M. Blepharospasm: recent advances. Neurology. 2002, 59:1306-12. 10.1212\/01.wnl.0000027361.73814.0e","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-023-02086-1","article-title":"The Guillain-Mollaret triangle: a key player in motor coordination and control with implications for neurological disorders","volume":"46","author":"Ogut E","year":"2023","unstructured":"Ogut E, Armagan K, Tufekci D. The Guillain-Mollaret triangle: a key player in motor coordination and control with implications for neurological disorders. Neurosurg Rev. 2023, 46:181. 10.1007\/s10143-023-02086-1","journal-title":"Neurosurg Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040269","article-title":"Treatment of blepharospasm and oromandibular dystonia with botulinum toxins","volume":"12","author":"Hassell TJ","year":"2020","unstructured":"Hassell TJ, Charles D. Treatment of blepharospasm and oromandibular dystonia with botulinum toxins. Toxins (Basel). 2020, 12:269. 10.3390\/toxins12040269","journal-title":"Toxins (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson DM","year":"2016","unstructured":"Simpson DM, Hallett M, Ashman EJ, et al.. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016, 86:1818-26. 10.1212\/WNL.0000000000002560","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.37.4.616","article-title":"Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study","volume":"37","author":"Jankovic J","year":"1987","unstructured":"Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987, 37:616-23. 10.1212\/wnl.37.4.616","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21580","article-title":"Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome)","volume":"22","author":"Ostrem JL","year":"2007","unstructured":"Ostrem JL, Marks WJ Jr, Volz MM, Heath SL, Starr PA. Pallidal deep brain stimulation in patients with cranial-cervical dystonia (Meige syndrome). Mov Disord. 2007, 22:1885-91. 10.1002\/mds.21580","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23549","article-title":"Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation","volume":"26","author":"Reese R","year":"2011","unstructured":"Reese R, Gruber D, Schoenecker T, et al.. Long-term clinical outcome in meige syndrome treated with internal pallidum deep brain stimulation. Mov Disord. 2011, 26:691-8. 10.1002\/mds.23549","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2003.08.011","article-title":"Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome","volume":"96","author":"M\u00f8ller E","year":"2003","unstructured":"M\u00f8ller E, Werdelin LM, Bakke M, Dalager T, Prytz S, Regeur L. Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003, 96:544-9. 10.1016\/j.tripleo.2003.08.011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh P","year":"1995","unstructured":"Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve. 1995, 18:720-9. 10.1002\/mus.880180708","journal-title":"Muscle Nerve"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/194887-a-presentation-of-meige-syndrome-with-associated-upper-motor-neuron-symptoms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T17:08:47Z","timestamp":1715447327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/194887-a-presentation-of-meige-syndrome-with-associated-upper-motor-neuron-symptoms"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.60101","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,11]]}}}